Ticker HubNasdaq

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS

Latest price

$21.02+3.14%

As of Oct 26, 2026, 5:32 PM EDT · Market data by Massive

Market cap

$7.1B

Volume

Previous close

$20.38

Day range

$20.54 – $21.14

Listed

May 7, 2018

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $19.18Latest interval $21.02

Newsroom

Latest AMRX coverage

CompanyDeep DiveJan 8, 2026

Amneal Pharmaceuticals’ 2026 Outlook: Can the Rally Extend After a 70% Run?

Amneal Pharmaceuticals (AMRX) has entered 2026 with powerful momentum after a year that reshaped investor sentiment around the stock.

AMRX

Company overview

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 8.5K
CIK: 0001723128

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

May 7, 2018

Listed

8.5K

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.